Ascletis Pharma (HKG:1672) said the first participant has been dosed in a global Phase III clinical program for ASC30, an oral drug being developed for long-term weight management and diabetes.
The program comprises two late-stage trials involving about 4,600 participants across the U.S., Europe and Canada to assess the drug's effectiveness, safety and tolerability, according to a Sunday Hong Kong bourse filing.
Shares of the company plunged over 5% in Monday's trade.
Sany Heavy Industry (HKG:6031, SHA:600031) said its board approved plans to establish an asset-backed special purpose vehicle and issue asset-backed securities under a financing lease, with a shelf size of up to 10 billion yuan, according to an Aug. 28 Hong Kong bourse filing.The securities will be backed by accounts receivable held by the company and its subsidiaries and may be issued in multiple tranches over two years, with each tranche having a duration of up to five years.SANY Group, the controlling shareholder, plans to subscribe for all subordinated securities, with total subscriptions capped at 1 billion yuan.
Tencent (HKG:0700) has released Hy4 preview, an open-source AI model with a total parameter footprint of 770 bytes and an activation parameter size of 49 bytes, according to an Aug 28 social media post.The model targets real-world productivity tasks, including coding, office analytics, game development, and scientific research.The model is now available through Tencent Cloud TokenHub, OpenRouter, and Tencent's productivity products.
Samsung Heavy Industries (KRX:010140) secured a 444.5 billion won contract to build two container ships for an unnamed African buyer, according to a filing with the Korean bourse on Monday.The contract is valid from Aug. 28, 2026, to Dec. 27, 2028. Payment will be made as construction progresses, the filing said.Shares of Samsung Heavy Industries fell more than 2% in recent trade.